Form 4: Intellia Therapeutics Director Georgia Keresty Reports Stock and Option Transactions

Director Georgia Keresty reports acquisition of Intellia Therapeutics stock and stock options, and disposal of stock.

Summary

• On June 12, 2024, Georgia Keresty, a director of Intellia Therapeutics, acquired 7,737 shares of common stock at $0.00 and disposed of 23,883 shares.
• Keresty also acquired options to purchase 11,515 shares of common stock at an exercise price of $25.85, with the options expiring on June 11, 2034.
• The stock options vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders following the date of grant.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the director's view of the company's stock value.

Key Dates